Baraclude approved for chronic hepatitis B with decompensated liver disease - ONA
Links shared publicly online about this topic.
- 792total visits
Baraclude approved for chronic hepatitis B with decompensated liver disease - ONA
View full resource at oncologynurseadvisor.com
Tags: Liver, Liver Condition, Hepatitis, Hepatitis B, Hepatitis B Medication, Disease and Condition, Baraclude, disease
Most Recently Shared on October 18, 2010 at 3:14 pm By:
Baraclude approved for chronic hepatitis B with decompensated liver disease http://goo.gl/fb/n0M8K
BARACLUDE(R) (Entecavir) Approved By The European Commission For The Treatment Of CHB In Adult Patients With Evidence Of Decompensated Liver Disease
medicalnewstoday.com — “Bristol-Myers Squibb (NYSE:BMY) announced that BARACLUDE® (entecavir) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B (CHB) in adult patients wi” View full resource at medicalnewstoday.com
Most Recently Shared on March 2, 2011 at 9:05 am By:
BARACLUDE(R) (Entecavir) Approved By The European Commission For The Treatment Of CHB In Adult Patients With Evidence ... http://mnt.to/3RKX
U.S. Food and Drug Administration Approves Baraclude (entecavir) as a Treatment for Chronic Hepatitis B Patients with Evidence of Decompensated Liver Disease
drugs.com — “Baraclude (entecavir) is used for the treatment of chronic hepatitis B. Information from Drugs.com includes Baraclude side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 19, 2010 at 11:11 pm By:
Drugs and Devices OW OW Health
U.S. Food and Drug Administration Approves Baraclude (entecavir) as a Treatment for Chronic Hepatitis B Patie... http://bit.ly/clcQOM #drug
BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease
news-medical.net — “Bristol-Myers Squibb Company announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) of BARACLUDE for the treatment of chronic hepatitis B (CHB) in adult patients with decompensated liver disease.” View full resource at news-medical.net
Most Recently Shared on October 18, 2010 at 9:19 pm By:
Pregnancy News: BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver diseas... http://bit.ly/c7NTU3
Baraclude approved for chronic hepatitis B with decompensated liver disease - MPR
empr.com — “Baraclude approved for chronic hepatitis B with decompensated liver disease” View full resource at empr.com
Most Recently Shared on October 18, 2010 at 3:08 pm By:
MPR News: Baraclude approved for chronic hepatitis B with decompensated liver disease: Bristol-Myers Squibb announ... http://bit.ly/bu8nO5
Advertisement
